scholarly article | Q13442814 |
P50 | author | Elza Khusnutdinova | Q4502509 |
Alan Ashworth | Q4706084 | ||
Julian Peto | Q6307461 | ||
Jan Lubiński | Q11718282 | ||
Anne-Lise Børresen-Dale | Q11958220 | ||
Nazneen Rahman | Q16734865 | ||
Georgia Chenevix-Trench | Q17517031 | ||
Christine L. Clarke | Q56204859 | ||
Mikael Eriksson | Q56528259 | ||
Siranoush Manoukian | Q56697298 | ||
Anja Rudolph | Q56722646 | ||
John Hopper | Q56726496 | ||
Yon-Dschun Ko | Q114292610 | ||
Mitul Shah | Q114292631 | ||
Craig Luccarini | Q114292632 | ||
Helen Tsimiklis | Q114292641 | ||
Mervi Grip | Q114292643 | ||
Senno Verhoef | Q114292649 | ||
Hatef Darabi | Q114292651 | ||
Robert A E M Tollenaar | Q114292652 | ||
Ursula Eilber | Q114292658 | ||
Melanie J Maranian | Q114292661 | ||
Hans-Ulrich Ulmer | Q114337476 | ||
Darya Prokofyeva | Q114337497 | ||
Rohini Rau-Murthy | Q114337499 | ||
Primitiva Menéndez | Q114337513 | ||
Petra Seibold | Q114337534 | ||
Linetta B Koppert | Q114337603 | ||
Erik van Limbergen | Q114337620 | ||
Ruth Swann | Q114337660 | ||
Nicola Miller | Q115136498 | ||
Guillermo Pita | Q115136499 | ||
Michael Bremer | Q115727182 | ||
Zalina Takhirova | Q125345801 | ||
Roger L. Milne | Q56855807 | ||
Javier Benitez | Q56856067 | ||
Nasim Mavaddat | Q56875622 | ||
Joe Dennis | Q56875626 | ||
Vijai Joseph | Q56875726 | ||
Volker Arndt | Q57305816 | ||
Sajjad Rafiq | Q57320710 | ||
Mark N Brook | Q57517906 | ||
Jose Ignacio Arias Perez | Q57518122 | ||
Silje H. Nordgard | Q57973108 | ||
Christi J van Asperen | Q58235238 | ||
Anna Jakubowska | Q58323317 | ||
Louise A. Brinton | Q58623846 | ||
Anna Marie Mulligan | Q59659727 | ||
Anna González-Neira | Q30003814 | ||
Simon S. Cross | Q30505778 | ||
Alison Dunning | Q30506457 | ||
Robert N. Luben | Q30506463 | ||
Graham Giles | Q30524411 | ||
Montserrat García-Closas | Q28356305 | ||
Loic Le Marchand | Q28360612 | ||
Kamila Czene | Q28484009 | ||
Angela Cox | Q28484012 | ||
Hiltrud Brauch | Q28484013 | ||
Barbara Burwinkel | Q28484015 | ||
Ute Hamann | Q28484017 | ||
Jolanta Lissowska | Q28606996 | ||
Hermann Brenner | Q28958315 | ||
Kristiina Aittomäki | Q29840622 | ||
Heli Nevanlinna | Q29840669 | ||
Esther M. John | Q59752419 | ||
Sune G. Nielsen | Q59763235 | ||
Douglas F. Easton | Q59812154 | ||
Anthony Swerdlow | Q60492223 | ||
Leslie Bernstein | Q60607806 | ||
Frank Dudbridge | Q60878633 | ||
Diana Eccles | Q61756107 | ||
Paul D P Pharoah | Q61822938 | ||
Per Hall | Q62593354 | ||
Alfons Meindl | Q63015490 | ||
Fergus J. Couch | Q63018779 | ||
Susan L Neuhausen | Q63019538 | ||
Ian Tomlinson | Q63213090 | ||
Asta Försti | Q63213696 | ||
Peter A. Fasching | Q64005064 | ||
Fredrick Schumacher | Q64183024 | ||
Arif B. Ekici | Q64409983 | ||
Annika Lindblom | Q64516098 | ||
Jacques Simard | Q64516110 | ||
Irene L Andrulis | Q64516140 | ||
Wei Zheng | Q67482021 | ||
Clare Turnbull | Q67482869 | ||
Catriona A. McLean | Q68267862 | ||
Jianjun Liu | Q68692572 | ||
Jonine Figueroa | Q71778357 | ||
Sara Margolin | Q72940025 | ||
Matthias W. Beckmann | Q72940290 | ||
Stig Egil Bojesen | Q72992763 | ||
Christopher A. Haiman | Q73606228 | ||
Kenneth Offit | Q20732365 | ||
David J. Hunter | Q21066148 | ||
Jenny Chang-Claude | Q21263057 | ||
Rita Schmutzler | Q21264574 | ||
Diether Lambrechts | Q26923514 | ||
Stephen Chanock | Q27662321 | ||
Hoda Anton-Culver | Q28052887 | ||
Veli-Matti Kosma | Q37068464 | ||
Katarzyna Durda | Q37068937 | ||
Vesa Kataja | Q37069167 | ||
Arja Jukkola-Vuorinen | Q37069253 | ||
Arto Mannermaa | Q37070123 | ||
Pascal Guénel | Q37070260 | ||
Kyriaki Michailidou | Q37070465 | ||
Dieter Flesch-Janys | Q37071144 | ||
Katri Pylkäs | Q37071955 | ||
Thérèse Truong | Q37072552 | ||
Drakoulis Yannoukakos | Q37073411 | ||
Robert Winqvist | Q37074224 | ||
Antoinette Hollestelle | Q37074515 | ||
Andreas Schneeweiss | Q37074948 | ||
Aida Karina Dieffenbach | Q37075433 | ||
Argyrios Ziogas | Q30831638 | ||
Shan Wang-Gohrker | Q30831711 | ||
Katarzyna Jaworska-Bieniek | Q37075915 | ||
Caroline Seynaeve | Q37342673 | ||
Thilo Dörk | Q37342847 | ||
Florence Menegaux | Q37358234 | ||
Marina Bermisheva | Q37360473 | ||
Peter Devilee | Q37361664 | ||
Paolo Peterlongo | Q37361857 | ||
Taru A. Muranen | Q37371838 | ||
Minouk J Schoemaker | Q37371896 | ||
Jingmei Li | Q37371985 | ||
Marjanka K Schmidt | Q37372106 | ||
Paolo Radice | Q37372139 | ||
Sara Lindstroem | Q77022171 | ||
Peter Kraft | Q77526208 | ||
Julia A. Knight | Q78316584 | ||
Nick Orr | Q78318000 | ||
Janet E. Olson | Q78318964 | ||
Christa Stegmaier | Q78334823 | ||
Carmel Apicella | Q84487301 | ||
Thomas Brüning | Q84487350 | ||
Daniel R Tessier | Q86844345 | ||
Lothar Haeberle | Q87976657 | ||
Daniel Limones-Herrero | Q88173248 | ||
Frederik Marmé | Q88268377 | ||
Rulla M Tamimi | Q88477882 | ||
Amy Trentham-Dietz | Q88960210 | ||
Polly A Newcomb | Q89454622 | ||
William D Tap | Q90147379 | ||
Hans Christiansen | Q90373551 | ||
Vernon Pankratz | Q90603683 | ||
Peter Hillemanns | Q91084009 | ||
Jonathan P Tyrer | Q91084019 | ||
Hans Wildiers | Q91254016 | ||
Miriam V Dwek | Q92181262 | ||
Michael J Kerin | Q92359739 | ||
Christian Sutter | Q92480964 | ||
Susan L Slager | Q92530010 | ||
Mark P Goldberg | Q96133446 | ||
Anthony Renwick | Q96759345 | ||
Valeria Pensotti | Q97414997 | ||
Rosemary L Balleine | Q98177088 | ||
Jaana M Hartikainen | Q56204836 | ||
Emiel Rutgers | Q110419368 | ||
Peter Schürmann | Q113623412 | ||
Natalia Antonenkova | Q113623741 | ||
Manjeet K Bolla | Q114270702 | ||
Sheila Seal | Q114292602 | ||
Alice J Sigurdson | Q114292605 | ||
Michele M Doody | Q114292606 | ||
Ans M W van den Ouweland | Q114292607 | ||
Amanda Ewart Toland | Q38300105 | ||
Grethe Grenaker Alnæs | Q40177166 | ||
Tjoung-Won Park-Simon | Q42170981 | ||
Alice S. Whittemore | Q42423380 | ||
Sandra Deming-Halverson | Q42438267 | ||
France Labrèche | Q42439536 | ||
Keith Humphreys | Q43401810 | ||
Børge G. Nordestgaard | Q43530123 | ||
Isabel dos Santos Silva | Q46514218 | ||
Mark Robson | Q51026477 | ||
Shahana Ahmed | Q54208457 | ||
Melissa C. Southey | Q55446228 | ||
Carl Blomqvist | Q73625505 | ||
Annegien Broeks | Q73632596 | ||
Gord Glendon | Q73633107 | ||
Brian E. Henderson | Q73660621 | ||
Henrik Flyger | Q74012148 | ||
Malcolm W. R. Reed | Q74013381 | ||
Nichola Johnson | Q74014116 | ||
Maartje J. Hooning | Q74014444 | ||
Natalia V. Bogdanova | Q74171899 | ||
Elinor J. Sawyer | Q74173254 | ||
Celine M. Vachon | Q74173260 | ||
P2093 | author name string | Qin Wang | |
Diana Torres | |||
Judith Brown | |||
Rodney Scott | |||
Kathleen M Egan | |||
Christof Sohn | |||
Rongxi Yang | |||
Caroline Baynes | |||
Catherine S Healey | |||
Daniel Vincent | |||
Francois Bacot | |||
M Pilar Zamora | |||
M Rosario Alonso | |||
Marie Sanchez | |||
Martine Dumont | |||
Nuria Álvarez | |||
Song Yao | |||
Chantal Van Ongeval | |||
Linda Titus | |||
Jane Carpenter | |||
Katherine Annie Perkins | |||
P2860 | cites work | Prevention of breast cancer in the context of a national breast screening programme | Q57266562 |
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
Genome-wide association studies identify four ER negative-specific breast cancer risk loci | Q24622610 | ||
Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data | Q30620889 | ||
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study | Q33935171 | ||
Performance of common genetic variants in breast-cancer risk models | Q34064069 | ||
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information | Q34267477 | ||
The benefits and harms of breast cancer screening: an independent review | Q34309421 | ||
Effect of three decades of screening mammography on breast-cancer incidence | Q34313044 | ||
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer | Q34736112 | ||
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening | Q34977428 | ||
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium | Q35119701 | ||
Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening | Q35136955 | ||
The genetic epidemiology of breast cancer genes | Q35959353 | ||
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement | Q36393193 | ||
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors | Q36720821 | ||
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers | Q36742577 | ||
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | Q36897003 | ||
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status | Q37223335 | ||
Polygenes, risk prediction, and targeted prevention of breast cancer | Q81523323 | ||
A role for common genomic variants in the assessment of familial breast cancer | Q85312916 | ||
Public health implications from COGS and potential for risk stratification and screening | Q86499074 | ||
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium | Q37619303 | ||
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact | Q37632049 | ||
Genetic susceptibility to breast cancer | Q41130542 | ||
Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci | Q42955271 | ||
Breast cancer screening: time to target women at risk | Q43128186 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P577 | publication date | 2015-04-08 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Prediction of breast cancer risk based on profiling with common genetic variants | |
P478 | volume | 107 |
Q90339863 | 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population |
Q38844517 | A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery |
Q37697979 | A clinical model for identifying the short-term risk of breast cancer |
Q33845912 | A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans |
Q38958555 | A polygenic risk score for breast cancer risk in a Taiwanese population. |
Q46258028 | A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies |
Q57748350 | Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study |
Q38662947 | Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers |
Q89534097 | Adventures in the environment and genes |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q58613780 | Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC) |
Q33767039 | An alternative model for (breast) cancer predisposition |
Q39551156 | An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer |
Q56893420 | Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies |
Q90051408 | Assessing thyroid cancer risk using polygenic risk scores |
Q38776757 | Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study |
Q57612089 | Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative |
Q52576610 | Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. |
Q60309353 | Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes |
Q39500666 | Beyond Endometriosis Genome-Wide Association Study: From Genomics to Phenomics to the Patient |
Q42363834 | Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers |
Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
Q87909686 | Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening |
Q36619329 | Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry |
Q30238753 | Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. |
Q40605693 | Breast cancer risk prediction using a clinical risk model and polygenic risk score |
Q37410693 | Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab |
Q52586080 | Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families? |
Q35834376 | Can the breast screening appointment be used to provide risk assessment and prevention advice? |
Q91211233 | Cancer genetics, precision prevention and a call to action |
Q92475989 | Chromatin interactome mapping at 139 independent breast cancer risk signals |
Q92282006 | Cirrus: An Automated Mammography-Based Measure of Breast Cancer Risk Based on Textural Features |
Q89746441 | Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field |
Q59238197 | Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation |
Q37364628 | Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies |
Q64458461 | Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma |
Q47703662 | Common Genetic Variation and Breast Cancer Risk - Past, present, and future |
Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
Q38804228 | Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas |
Q52584688 | Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group. |
Q31064480 | Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk |
Q38444625 | Cross-Phenotype Polygenic Risk Score Analysis of Persistent Post-Concussive Symptoms in U.S. Army Soldiers with Deployment-Acquired Traumatic Brain Injury |
Q47298550 | Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants |
Q30251440 | Developing and evaluating polygenic risk prediction models for stratified disease prevention |
Q37138925 | Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial |
Q57108215 | Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses |
Q64058041 | Epidemiological characteristics of and risk factors for breast cancer in the world |
Q38368693 | Epidemiology of Esophageal Squamous Cell Carcinoma. |
Q92103705 | Epithelial ovarian cancer risk: A review of the current genetic landscape |
Q98184153 | European polygenic risk score for prediction of breast cancer shows similar performance in Asian women |
Q33614244 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers |
Q57172770 | Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study |
Q55040393 | Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese. |
Q38739215 | Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk. |
Q48029327 | Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families |
Q50051819 | Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. |
Q45963434 | Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1). |
Q90374343 | Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic |
Q64087937 | Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control |
Q99633744 | Gene panel screening for insight towards breast cancer susceptibility in different ethnicities |
Q26772236 | Gene-environment interaction and risk of breast cancer |
Q42868000 | Genetic Determinants of Breast Cancer Risk in Childhood Cancer Survivors |
Q47945968 | Genetic Test, Risk Prediction, and Counseling. |
Q64080586 | Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer |
Q36316307 | Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score |
Q50057756 | Genetic determinants of sporadic breast cancer in Sri Lankan women. |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q91235528 | Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders |
Q62583135 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma |
Q47207156 | Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry |
Q33609333 | Genetics for population and public health |
Q92471097 | Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland |
Q59756250 | Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer |
Q91525724 | Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico |
Q38608277 | High-Definition Medicine |
Q64934338 | High-risk women's risk perception after receiving personalized polygenic breast cancer risk information. |
Q37670725 | Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort. |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q90460444 | Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test |
Q48717652 | Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials. |
Q40310422 | Implications of polygenic risk for personalised colorectal cancer screening |
Q92711915 | Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore |
Q92281992 | Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer |
Q37378034 | Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model |
Q53400538 | Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density. |
Q48181769 | Inherited factors contribute to an inverse association between preeclampsia and breast cancer |
Q37360550 | Integrating precision cancer medicine into healthcare-policy, practice, and research challenges |
Q89866318 | Interactions between a Polygenic Risk Score and Non-genetic Risk Factors in Young-Onset Breast Cancer |
Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
Q33829049 | Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction |
Q40089754 | Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. |
Q96302976 | Key steps for effective breast cancer prevention |
Q33825680 | Leveraging functional annotations in genetic risk prediction for human complex diseases |
Q37513545 | Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study). |
Q43843244 | Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction |
Q54730200 | Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening. |
Q58769239 | Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls |
Q47822347 | Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks. |
Q36298470 | Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms. |
Q41010078 | Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk |
Q37463923 | Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors. |
Q58556516 | Multi-gene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families |
Q24658557 | Multigene testing of moderate-risk genes: be mindful of the missense |
Q49553408 | Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations. |
Q93059865 | Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort |
Q36591738 | Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations |
Q91892103 | PRSice-2: Polygenic Risk Score software for biobank-scale data |
Q36574725 | Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity |
Q57453316 | Personalised medicine and population health: breast and ovarian cancer |
Q92323619 | Perspective: The Clinical Use of Polygenic Risk Scores: Race, Ethnicity, and Health Disparities |
Q58113261 | Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE) |
Q26750522 | Polygenic Epidemiology |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q88666837 | Polygenic Risk Scores: What Are They Good For? |
Q92638472 | Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification |
Q37131918 | Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families |
Q57172887 | Polygenic risk score of shorter telomere length and risk of depression and anxiety in women |
Q97524107 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants |
Q92966277 | Polygenic risk-stratified screening for cancer: Responsibilization in public health genomics |
Q96163551 | Practical implementation of frailty models in Mendelian risk prediction |
Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
Q37487782 | Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry |
Q47409320 | Predictive accuracy of combined genetic and environmental risk scores |
Q40474074 | Previous GWAS hits in relation to young-onset breast cancer. |
Q36229139 | Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda |
Q47574889 | Prospects for using risk scores in polygenic medicine |
Q33916899 | Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study |
Q31046674 | Reclassification of genetic-based risk predictions as GWAS data accumulate |
Q37524981 | Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies |
Q37101570 | Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk |
Q92710828 | Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients |
Q36545643 | Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population |
Q54950358 | Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. |
Q58696903 | SNP interactions of PGC with its neighbor lncRNAs enhance the susceptibility to gastric cancer/atrophic gastritis and influence the expression of involved molecules |
Q36322904 | SNPs and breast cancer risk prediction for African American and Hispanic women |
Q97883645 | SNPs in lncRNA Regions and Breast Cancer Risk |
Q55013059 | Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. |
Q52648599 | Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia. |
Q92276452 | Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis |
Q92187296 | Somatic variants of potential clinical significance in the tumors of BRCA phenocopies |
Q33734235 | Structure-Leveraged Methods in Breast Cancer Risk Prediction |
Q92993050 | Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts |
Q36545434 | Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer |
Q37444608 | Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes |
Q38842051 | Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer. |
Q47161591 | The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol. |
Q28552519 | The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study |
Q92282029 | The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches |
Q41701590 | The WISDOM Study: breaking the deadlock in the breast cancer screening debate |
Q28074414 | The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance |
Q88778863 | The personal and clinical utility of polygenic risk scores |
Q49356370 | The use of panel testing in familial breast and ovarian cancer. |
Q64240122 | Towards a more precise and individualized assessment of breast cancer risk |
Q47397232 | Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach |
Q42366133 | Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer |
Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
Q52632715 | Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. |
Q59335358 | Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer |
Q64102998 | Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer |
Q64273108 | Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel |
Q90092211 | Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known Therapies |
Q36255311 | Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention |
Q57040851 | Validation of a genetic risk score for Arkansas women of color |
Q97093695 | Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort |
Q28917124 | Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data |
Q36678510 | iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management |
Search more.